UPDATE 2-US FDA clears Vivos Therapeutics ' oral device for sleep apnea

Vivos Therapeutics said on Wednesday the U.S. health regulator has cleared its oral device for severe obstructive sleep apnea (OSA), leading a massive rally in the company's shares before the bell. Shares of the medical device maker more than doubled to $9.12 in premarket trading. The clearance is…#vivostherapeutics #philips #fda #bengaluru #shilpimajumdar
Source: Reuters: Health - Category: Consumer Health News Source Type: news